公开(公告)号：US20240066047A1

公开(公告)日：2024-02-29

申请号：US18310467

申请日：2023-05-01

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： MASATO YOSHIKAWA ,  MORIHISA SAITOH ,  TAISUKE KATO ,  YAYOI NAKAYAMA ,  TOMOHIRO SEKI ,  YASUO NAKAGAWA ,  YUSUKE TOMINARI ,  MASAKI SETO ,  YUSUKE SASAKI ,  MASANORI OKANIWA ,  TSUNEO ODA ,  AKITO SHIBUYA ,  KOSUKE HIDAKA ,  ZENYU SHIOKAWA ,  SHUMPEI MURATA ,  ATSUTOSHI OKABE ,  YOSHIHISA NAKADA ,  MICHIYO MOCHIZUKI ,  BRIAN SCOTT FREEZE ,  TAISUKE TAWARAISHI ,  YASUFUMI WADA ,  PAUL D. GREENSPAN

IPC: A61K31/7084 ,  A61P35/00 ,  C07H21/00 ,  C07H21/02 ,  A61K47/68 ,  A61K31/7076

CPC classification number: A61K31/7084 ,  A61P35/00 ,  C07H21/00 ,  C07H21/02 ,  A61K47/6807 ,  A61K31/7076

Abstract: The present disclosure provides a compound having a STING agonistic activity, which may be expected to be useful as an agent for the prophylaxis or treatment of STING-related diseases.
The present disclosure relates to a compound represented by the formula (I):




wherein each symbol is as defined in the description, or a salt thereof.